Cargando…
A first-in-human study of [(68)Ga]Ga-CDI: a positron emitting radiopharmaceutical for imaging tumour cell death
PURPOSE: This study assesses human biodistribution, radiation dosimetry, safety and tumour uptake of cell death indicator labelled with (68)Ga ([(68)Ga]Ga-CDI), a novel radiopharmaceutical that can image multiple forms of cell death. METHODS: Five participants with at least one extracranial site of...
Autores principales: | Ho Shon, Ivan, Hennessy, Thomas, Guille, Jennifer, Gotsbacher, Michael P., Lay, Angelina J., McBride, Bruce, Codd, Rachel, Hogg, Philip J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9525422/ https://www.ncbi.nlm.nih.gov/pubmed/35779082 http://dx.doi.org/10.1007/s00259-022-05880-z |
Ejemplares similares
-
Prospective of (68)Ga-Radiopharmaceutical Development
por: Velikyan, Irina
Publicado: (2013) -
[(68)Ga]Ga-DOTA-TOC: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging
por: Hennrich, Ute, et al.
Publicado: (2020) -
Good practices for (68)Ga radiopharmaceutical production
por: Nelson, Bryce J. B., et al.
Publicado: (2022) -
[(68)Ga]Ga-PSMA-11: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
por: Hennrich, Ute, et al.
Publicado: (2021) -
(68)Ga-Based Radiopharmaceuticals: Production and Application Relationship
por: Velikyan, Irina
Publicado: (2015)